AVITA Medical to Present at TD Cowen’s 45ᵗʰ Annual Health Care Conference

Rhea-AI Summary

AVITA Medical (NASDAQ: RCEL), a therapeutic acute wound care company, has announced its upcoming participation in TD Cowen's 45th Annual Health Care Conference. Jim Corbett, the company's Chief Executive Officer, is scheduled to present on Tuesday, March 4, 2025, at 11:50 a.m. Eastern Time.

The presentation will be accessible through a live audio webcast on the Events & Presentations section of AVITA Medical's investor relations website. Interested parties can access the webcast at https://ir.avitamedical.com, and a replay will be made available after the event concludes.

News Market Reaction – RCEL

-7.48%

-7.48% Session move

In the trading session that priced this news, RCEL declined 7.48%, reflecting a notable negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

VALENCIA, Calif., Feb. 26, 2025 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a leading therapeutic acute wound care company delivering transformative solutions, today announced that Jim Corbett, Chief Executive Officer, will present at TD Cowen’s 45^th Annual Health Care Conference on Tuesday, March 4, 2025, at 11:50 a.m. Eastern Time.

A live audio webcast of the presentation will be accessible under the Events & Presentations section of the Company's website at https://ir.avitamedical.com. A replay of the webcast will be available following the conclusion of the event.

About AVITA Medical, Inc.
AVITA Medical^® is a leading therapeutic acute wound care company delivering transformative solutions. Our technologies are designed to optimize wound healing, effectively accelerating the time to patient recovery. At the forefront of our platform is the RECELL^® System, approved by the U.S. Food and Drug Administration for the treatment of thermal burn wounds and full-thickness skin defects. RECELL harnesses the healing properties of a patient’s own skin to create Spray-On Skin^™ Cells, offering an innovative solution for improved clinical outcomes at the point-of-care. In the U.S., AVITA Medical also holds the exclusive rights to market, sell, and distribute Cohealyx^™, an AVITA Medical-branded collagen-based dermal matrix, and PermeaDerm^®, a biosynthetic wound matrix.

In international markets, the RECELL System is approved to promote skin healing in a wide range of applications including burns and full-thickness skin defects. The RECELL System, excluding RECELL GO^®, is TGA-registered in Australia, has received CE mark approval in Europe, and has PMDA approval in Japan.

To learn more, visit www.avitamedical.com.

Authorized for release by the Chief Financial Officer of AVITA Medical, Inc.

FAQ

When is AVITA Medical (RCEL) presenting at TD Cowen's Healthcare Conference 2025?

AVITA Medical will present on Tuesday, March 4, 2025, at 11:50 a.m. Eastern Time.

How can investors watch AVITA Medical's (RCEL) TD Cowen conference presentation?

Investors can watch via live audio webcast at https://ir.avitamedical.com under the Events & Presentations section.

Will there be a replay available of AVITA Medical's (RCEL) TD Cowen presentation?

Yes, a replay of the webcast will be available on AVITA Medical's investor relations website after the event.

Who is presenting for AVITA Medical (RCEL) at the TD Cowen Healthcare Conference?

Jim Corbett, AVITA Medical's Chief Executive Officer, will present at the conference.